deltatrials

Mayo Clinic Clinical Trials

Sponsors / Mayo Clinic

2,823 ClinicalTrials.gov entries name Mayo Clinic as the lead sponsor. The portfolio currently includes 502 recruiting studies, 150 active non-recruiting studies, and 1729 completed studies. 259 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Cumulative planned enrollment across all listed trials is 13,017,063 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

2,823
Total Trials
502
Recruiting
150
Other Active
1,729
Completed
259
Terminated / Withdrawn
13,017,063
Total Enrollment

Termination reasons: Recruitment44% · Other28% · Funding17% · Efficacy5% · PI/or_Site4% · Regulatory1% · Safety1%

Recent Terminations

  • NCT06564051 Stopped Dec 2025
    Chronic Viral Hepatitis C
    "slow accrual"
  • NCT06420349 Phase PHASE1 Stopped Sep 2025
    Advanced Cholangiocarcinoma
    "study sponsor phasing out drug supply"
  • NCT06347809 Stopped Jul 2025
    Prostate Adenocarcinoma
    "Closed to consolidate enrollment under another related study"
  • NCT05992896 Phase PHASE4 Stopped Jun 2025
    Peripheral Arterial Disease
    "Lack of funds"
  • NCT05820997 Phase PHASE4 Stopped Dec 2024
    Pancreaticoduodenectomy
    "Low accrual"
  • NCT06238986 Stopped Nov 2024
    Anatomic Stage I Breast Cancer AJCC v8
    "Lack of funding"
  • NCT06511388 Stopped Oct 2024
    Sarcoma
    "Low accrual"
  • NCT06002074 Phase NA Stopped Sep 2024
    Inflammatory Bowel Diseases
    "PI Decision to end study"
  • NCT05904769 Phase NA Stopped Jul 2024
    Diabetes
    "Lack of staffing support"
  • NCT06016504 Phase NA Stopped Jul 2024
    Prostate Carcinoma
    "Low/slow accrual"

Active Trials (150 total)

See all 150 active trials

Top Conditions

Top Locations